# Aprea Therapeutics, Inc.: Form 8-K, filed Feb 18, 2026

- Company: [Aprea Therapeutics, Inc.](/companies/apre.md) (CIK 1781983)
- Form: 8-K
- Filed: 2026-02-18
- Accepted by EDGAR: Feb 18, 2026, 08:30 ET
- Period: 2026-02-18
- Accession: 0001104659-26-016797
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1781983/000110465926016797/tm266669d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1781983/000110465926016797/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1781983/000110465926016797/tm266669d1_8k.htm

Filed Feb 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-016797. Last ingested by Listed: Nov 4, 2026, 08:47 ET. No prices; not investment advice.